-- 明和(东京证券交易所代码:8103)2025财年归属于母公司股东的净利润同比下降0.1%至33.7亿日元,而上年同期为33.8亿日元。 根据周四提交给东京证券交易所的文件,这家日本贸易公司的基本每股收益从上年同期的83.28日元增至83.99日元。 截至3月31日的财年,净销售额同比增长5.2%至1649亿日元,而上年同期为1567亿日元。 明和宣布派发末期股息,每股42日元。 该公司预计2026财年归属于股东的净利润为37亿日元,基本每股收益为93.53日元,净销售额为1700亿日元。 明和股价在收盘时上涨近3%。
Related Articles
Research Alert: Mg: Q1 Earnings Well Ahead Of Expectations; Guidance Revisions Mixed
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Magna International (MG) posted Q1 adjusted EPS of $1.38 vs. $0.78 (+77%), well ahead of the $1.01 consensus, owing to much stronger-than-expected sales and margins, as revenue rose 3.1% to $10.38B ($110M above consensus) and adjusted EBIT margin expanded 190 bps to 5.4% (120 bps above consensus). MG lowered 2026 revenue guidance to $41.5B-$43.1B from $41.9B-$43.5B (current consensus: $42.4B). The only other change to previous guidance was a reduction in its net interest expense expectation to $165M from $180M. Other prior guidance was unchanged. While the company did not raise full-year EPS guidance, we think a raise is now more likely given the magnitude of the beat, although we think management's caution is understandable given current macro uncertainties. Given MG's broad product diversification across the automotive parts and equipment space, and status as the largest North American auto supplier, we think the strength of its Q1 results has positive implications for other auto suppliers.
Stifel Nicolaus Initiates Coverage on Septerna With Buy Rating, $43 Price Target
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Stifel Nicolaus Initiates Coverage on Evommune With Buy Rating, $54 Price Target
Evommune, Inc. (EVMN) has an average rating of Buy and mean price target of $52, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)